Variant report
Variant | nsv437967 |
---|---|
Chromosome Location | chr6:33938296-33942228 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9469656 | chr6:33938296-33938297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563527752 | chr6:33938300-33938301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112006671 | chr6:33938316-33938317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567107594 | chr6:33938340-33938341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569936982 | chr6:33938363-33938364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186989049 | chr6:33938381-33938382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564483054 | chr6:33938390-33938391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528792584 | chr6:33938402-33938403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2495973 | chr6:33938403-33938404 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs192987427 | chr6:33938485-33938486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535517750 | chr6:33938566-33938567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369273602 | chr6:33938635-33938636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550723481 | chr6:33938646-33938647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569067737 | chr6:33938654-33938655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184796398 | chr6:33938683-33938684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145263380 | chr6:33938708-33938709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs578239103 | chr6:33938760-33938761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373518220 | chr6:33938798-33938799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111722480 | chr6:33938879-33938880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111919253 | chr6:33938892-33938893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190047925 | chr6:33938970-33938971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553300303 | chr6:33939062-33939063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574777284 | chr6:33939079-33939080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542290078 | chr6:33939133-33939134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2499756 | chr6:33939156-33939157 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546866944 | chr6:33939190-33939191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575424710 | chr6:33939227-33939228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2495974 | chr6:33939250-33939251 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs529088942 | chr6:33939332-33939333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373918890 | chr6:33939401-33939402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528748292 | chr6:33939409-33939410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181813569 | chr6:33939424-33939425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71567414 | chr6:33939445-33939446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375977685 | chr6:33939476-33939477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374397212 | chr6:33939483-33939484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184780366 | chr6:33939486-33939487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528925419 | chr6:33939538-33939539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550475793 | chr6:33939541-33939542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568930038 | chr6:33939553-33939554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376504469 | chr6:33939558-33939559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539540368 | chr6:33939653-33939654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551576685 | chr6:33939659-33939660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566567659 | chr6:33939696-33939697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs58624907 | chr6:33939700-33939701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555404980 | chr6:33939736-33939737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150221296 | chr6:33939753-33939754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373815578 | chr6:33939760-33939761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556946188 | chr6:33939766-33939767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575288806 | chr6:33939807-33939808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377158430 | chr6:33939937-33939938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:33927000-33942400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:33934800-33943600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:33941800-33942800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:33941800-33942800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:33941800-33942800 | Bivalent/Poised TSS | Rectal Mucosa Donor 29 | rectum |
6 | chr6:33942000-33942200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr6:33942000-33942400 | Active TSS | Rectal Mucosa Donor 31 | rectum |
8 | chr6:33942000-33942600 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
9 | chr6:33942000-33942800 | Enhancers | H1 Cell Line | embryonic stem cell |